{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:59:39Z","timestamp":1788242379281,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["HEAF673100100"],"award-info":[{"award-number":["HEAF673100100"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["390252002"],"award-info":[{"award-number":["390252002"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary and Animal Science"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.vas.2025.100510","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:46:11Z","timestamp":1758134771000},"page":"100510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pilot study on the effects of dapagliflozin on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Nakkawee","family":"Saengklub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusak","family":"Kijtawornrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Hamlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vas.2025.100510_bib0001","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","article-title":"Secondary mitral regurgitation in heart failure: Pathophysiology, prognosis, and therapeutic considerations","volume":"65","author":"Asgar","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.vas.2025.100510_bib0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jvc.2012.02.002","article-title":"Pharmacologic management of myxomatous mitral valve disease in dogs","volume":"14","author":"Atkins","year":"2012","journal-title":"Journal of veterinary cardiology"},{"issue":"6","key":"10.1016\/j.vas.2025.100510_bib0003","doi-asserted-by":"crossref","first-page":"640","DOI":"10.33963\/v.phj.100613","article-title":"The impact of using SGLT-2 inhibitor on left ventricular longitudinal strain and NT-proBNP levels during six-month follow-up in diabetic patients with and without coronary artery disease with preserved ejection fraction","volume":"82","author":"Biter","year":"2024","journal-title":"Kardiologia polska"},{"issue":"3","key":"10.1016\/j.vas.2025.100510_bib0004","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/jc.2011-2260","article-title":"Effects of Dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on Metformin","volume":"97","author":"Bolinder","year":"2012","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/j.vas.2025.100510_bib0005","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/jvim.14586","article-title":"Effect of Pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: The EPIC Study-A randomized clinical trial","volume":"30","author":"Boswood","year":"2016","journal-title":"Journal of veterinary internal medicine"},{"issue":"12","key":"10.1016\/j.vas.2025.100510_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008837","article-title":"Efficacy and safety of Dapagliflozin in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide: Insights from the DAPA-HF trial","volume":"14","author":"Butt","year":"2021","journal-title":"Circulation. Heart failure"},{"issue":"1","key":"10.1016\/j.vas.2025.100510_bib0007","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jvc.2011.11.003","article-title":"Differentiating the aging of the mitral valve from human and canine myxomatous degeneration","volume":"14","author":"Connell","year":"2012","journal-title":"Journal of Veterinary Cardiology"},{"issue":"12","key":"10.1016\/j.vas.2025.100510_bib0008","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/vetsci11120594","article-title":"Echocardiographic changes in dogs with stage B2 myxomatous mitral valve disease treated with Pimobendan monotherapy","volume":"11","author":"Crosland","year":"2024","journal-title":"Veterinary sciences"},{"issue":"27","key":"10.1016\/j.vas.2025.100510_bib0009","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000043171","article-title":"Efficacy and outcomes of dapagliflozin in diabetic nephropathy: A systematic review and meta-analysis","volume":"104","author":"Dahal","year":"2025","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.vas.2025.100510_bib0010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.5455\/OVJ.2021.v11.i4.13","article-title":"Assessment of heart rate turbulence in dogs with myxomatous mitral valve disease","volume":"11","author":"Dos Santos","year":"2021","journal-title":"Open Veterinary Journal"},{"issue":"2","key":"10.1016\/j.vas.2025.100510_bib0011","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/00325481.2019.1581971","article-title":"SGLT2 inhibitors and cardioprotection: A matter of debate and multiple hypotheses","volume":"131","author":"Filippatos","year":"2019","journal-title":"Postgraduate Medicine"},{"issue":"1","key":"10.1016\/j.vas.2025.100510_bib0012","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jvc.2012.02.001","article-title":"Pathology of myxomatous mitral valve disease in the dog","volume":"14","author":"Fox","year":"2012","journal-title":"Journal of Veterinary Cardiology"},{"issue":"8","key":"10.1016\/j.vas.2025.100510_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2460\/javma.24.01.0039","article-title":"Oscillometric and doppler techniques can provide continuous noninvasive blood pressure readings in cats and dogs: An instructional video","volume":"262","author":"Haginoya","year":"2024","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.vas.2025.100510_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.602251","article-title":"Safety and efficacy of adding Dapagliflozin to Furosemide in type 2 diabetic patients with decompensated heart failure and reduced ejection fraction","volume":"7","author":"Ibrahim","year":"2020","journal-title":"Frontiers in Cardiovascular medicine"},{"issue":"6","key":"10.1016\/j.vas.2025.100510_bib0015","first-page":"642","article-title":"Hypoglycemia in dogs: Causes, management, and diagnosis","volume":"59","author":"Idowu","year":"2018","journal-title":"The Canadian Veterinary Journal = La revue Veterinaire Canadienne"},{"issue":"3","key":"10.1016\/j.vas.2025.100510_bib0016","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/jvim.15488","article-title":"ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs","volume":"33","author":"Keene","year":"2019","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"4","key":"10.1016\/j.vas.2025.100510_bib0017","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1292\/jvms.16-0372","article-title":"Long-term effect of sildenafil on echocardiographic parameters in dogs with asymptomatic myxomatous mitral valve degeneration","volume":"79","author":"Kijtawornrat","year":"2017","journal-title":"The Journal of veterinary medical science"},{"issue":"8","key":"10.1016\/j.vas.2025.100510_bib0018","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3949\/ccjm.92a.24071","article-title":"Managing the side effects of sodium-glucose cotransporter-2 inhibitors","volume":"92","author":"Kodur","year":"2025","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"1","key":"10.1016\/j.vas.2025.100510_bib0019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12933-020-01066-9","article-title":"Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia\/reperfusion injury","volume":"19","author":"Lahnwong","year":"2020","journal-title":"Cardiovascular Diabetology"},{"issue":"7","key":"10.1016\/j.vas.2025.100510_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019274","article-title":"Dapagliflozin improves cardiac hemodynamics and mitigates arrhythmogenesis in mitral regurgitation-induced myocardial dysfunction","volume":"10","author":"Lin","year":"2021","journal-title":"Journal of the American Heart Association"},{"issue":"21","key":"10.1016\/j.vas.2025.100510_bib0021","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"The New England Journal of Medicine"},{"issue":"18","key":"10.1016\/j.vas.2025.100510_bib0022","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.119.042929","article-title":"Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction: The DEFINE-HF trial","volume":"140","author":"Nassif","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.vas.2025.100510_bib0023","series-title":"Guide for the care and use of laboratory animals","year":"2011"},{"issue":"1","key":"10.1016\/j.vas.2025.100510_bib0024","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12917-023-03770-6","article-title":"Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs","volume":"19","author":"Pirintr","year":"2023","journal-title":"BMC Veterinary research"},{"key":"10.1016\/j.vas.2025.100510_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.700230","article-title":"Short-term effects of Sacubitril\/valsartan on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease","volume":"8","author":"Saengklub","year":"2021","journal-title":"Frontiers in Veterinary Science"},{"issue":"7","key":"10.1016\/j.vas.2025.100510_bib0026","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.3390\/ijms23073651","article-title":"An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors","volume":"23","author":"Salvatore","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.vas.2025.100510_bib0027","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/dc19-2187","article-title":"Dapagliflozin versus placebo on left ventricular remodeling in patients with diabetes and heart failure: The REFORM trial","volume":"43","author":"Singh","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.vas.2025.100510_bib0028","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/ani14050772","article-title":"Self-reported utilization of international (ACVIM Consensus) guidelines and the latest clinical trial results on the treatment of dogs with various stages of myxomatous mitral valve degeneration: A survey among Veterinary practitioners","volume":"14","author":"van Staveren","year":"2024","journal-title":"Animals"},{"issue":"6","key":"10.1016\/j.vas.2025.100510_bib0029","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/jvim.15863","article-title":"Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial","volume":"34","author":"Wess","year":"2020","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"6","key":"10.1016\/j.vas.2025.100510_bib0030","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s10741-022-10220-2","article-title":"Alterations of sodium-hydrogen exchanger 1 function in response to SGLT2 inhibitors: What is the evidence?","volume":"27","author":"Wichaiyo","year":"2022","journal-title":"Heart failure reviews"},{"issue":"1","key":"10.1016\/j.vas.2025.100510_bib0031","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FJC.0000000000001380","article-title":"Mechanisms of SGLT2 inhibitors in heart failure and their clinical value","volume":"81","author":"Xie","year":"2023","journal-title":"Journal of Cardiovascular pharmacology"},{"issue":"6","key":"10.1016\/j.vas.2025.100510_bib0032","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10557-018-6837-3","article-title":"Dapagliflozin attenuates Na+\/H+ exchanger-1 in cardiofibroblasts via AMPK activation","volume":"32","author":"Ye","year":"2018","journal-title":"Cardiovascular Drugs and Therapy"}],"container-title":["Veterinary and Animal Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451943X25000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451943X25000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:44:57Z","timestamp":1774885497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451943X25000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"alternative-id":["S2451943X25000821"],"URL":"https:\/\/doi.org\/10.1016\/j.vas.2025.100510","relation":{},"ISSN":["2451-943X"],"issn-type":[{"value":"2451-943X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot study on the effects of dapagliflozin on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease","name":"articletitle","label":"Article Title"},{"value":"Veterinary and Animal Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vas.2025.100510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100510"}}